Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Current and future perspectives in obstructive azoospermia

Precongress Course 1

Andrology    Special Interest Group Andrology


Course coordinators
Francesco Lotti (Italy), Alberto Pacheco Castro (Spain)

Course type
Advanced

Course description
This comprehensive course offers an up-to-date exploration of Obstructive Azoospermia (OA), bridging the gap between foundational diagnostics and cutting-edge clinical management. Over four specialised sessions, leading international experts will guide participants through the latest clinical, genetic, surgical, and reproductive outcomes associated with this condition.


Educational needs and expected outcomes
The course addresses the following essential clinical gaps:

  • OA Diagnostics: Standardising diagnostic criteria using advanced seminal and ultrasound characteristics.
  • Genetic Interpretation: Understanding CFTR and novel gene mutations, plus early counselling protocols.
  • Surgical Management: Resolving clinical dilemmas regarding obstructions and synchronous vs. asynchronous MESA or TESE. 
  • Prognosis & Safety: Providing evidence-based data on natural fertility, ART success, and offspring risks.

At the end of the course, participants will be able to:

  • Accurately diagnose OA by integrating modern prevalence data, etiology, and specific seminal and ultrasound characteristics.
  • Interpret genetic reports for congenital absence of the vas deferens, identifying CFTR and novel mutations to provide timely counselling for adolescent patients.
  • Select optimal surgical and retrieval strategies, confidently managing prostatic/ejaculatory obstructions and deciding between synchronous or asynchronous MESA or TESE. 
  • Counsel patients on outcomes and safety by providing evidence-based prognoses on natural fertility, ART success rates, and potential offspring risks.

Target audience
Gynecologists, urologists, andrologists, embryologists, geneticists, and reproductive medicine specialists.

 

Programme



Sunday 04 July 2027